Matches in SemOpenAlex for { <https://semopenalex.org/work/W3092474519> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W3092474519 abstract "Abstract Background Most of Harm Reduction Service (HRS) users represent a crucial high-risk population for blood borne infections, including HCV. With the advent of new direct antiviral agents (DAAs), HCV micro-elimination in this setting has become feasible. We evaluated HCV treatment cascade in two HRSs located in Milan. Methods We collected data on demographics, substance abuse history, HIV prevalence, HCV prevalence, testing and treatment on all register HRS users on 1 January 2019. Data collection was closed on 1 January 2020. Results A total of 881 HRS users (732M,149F) were included (median age: 45). The majority was addicted to heroin 67.5% (595), 24.1%(212) to cocaine, 5.3%(47) to THC and 3.1%(27) to other substances. The 28.0%(247/881) reported current or prior judiciary problems, 168/881(19.1%) were under psychiatric treatment. HCV serological screening (HCVAb) was performed for 587/881(66.7%), 113/881(12.8%) were in process, 2/881(0.2%) refused, 179/881(20.3%) were not HRS user anymore. 364/587(62%) resulted HCVAb positive, of whom 288(79.1%) were tested for HCV RNA. Among them 123/324(37.9%) were positive, 165/324(50.9%) were negative. Among HCVAb positive, 116/364(31.9%) were tested for HIV and 92(79.3%) resulted HIV positive. Among HCV RNA positive 92/123(74.8%) were initiated on DAAs treatment. Compliance to treatment was high; one treatment failure was registered. Individuals tested for HCV and HCVAb positive people had an average age significantly higher than the individuals not tested and HCVAb negative people (p < 0.001). Heroin user had a higher likelihood of being tested both for HCVAb and for HCV RNA and of being positive to the HCVAb test (p < 0.001). Conclusions Our study demonstrate that it is feasible to achieve good efficacy and compliance for HCV treatment among people who use drugs when decentralising treatment to HRS. To achieve the viral hepatitis elimination agenda goals, HRS-based model of treatment provision needs to be implemented at larger scale. Key messages Decentralising HCV test and treatment to harm reduction services is an effective strategy to achieve HCV micro-elimination among people who use drugs. Young people and people who are addicted to other substance than heroin resulted more difficult to link to HCV care through the harm reduction services. They require tailored intervention." @default.
- W3092474519 created "2020-10-15" @default.
- W3092474519 creator A5006814131 @default.
- W3092474519 creator A5014066269 @default.
- W3092474519 creator A5018536629 @default.
- W3092474519 creator A5031920023 @default.
- W3092474519 creator A5049585909 @default.
- W3092474519 creator A5051401821 @default.
- W3092474519 creator A5056694078 @default.
- W3092474519 creator A5061309508 @default.
- W3092474519 creator A5074865853 @default.
- W3092474519 creator A5086954268 @default.
- W3092474519 date "2020-09-01" @default.
- W3092474519 modified "2023-10-01" @default.
- W3092474519 title "Feasibility of HCV micro-elimination: HCV test and treatment in two harm reduction services in Milan" @default.
- W3092474519 doi "https://doi.org/10.1093/eurpub/ckaa165.668" @default.
- W3092474519 hasPublicationYear "2020" @default.
- W3092474519 type Work @default.
- W3092474519 sameAs 3092474519 @default.
- W3092474519 citedByCount "0" @default.
- W3092474519 crossrefType "journal-article" @default.
- W3092474519 hasAuthorship W3092474519A5006814131 @default.
- W3092474519 hasAuthorship W3092474519A5014066269 @default.
- W3092474519 hasAuthorship W3092474519A5018536629 @default.
- W3092474519 hasAuthorship W3092474519A5031920023 @default.
- W3092474519 hasAuthorship W3092474519A5049585909 @default.
- W3092474519 hasAuthorship W3092474519A5051401821 @default.
- W3092474519 hasAuthorship W3092474519A5056694078 @default.
- W3092474519 hasAuthorship W3092474519A5061309508 @default.
- W3092474519 hasAuthorship W3092474519A5074865853 @default.
- W3092474519 hasAuthorship W3092474519A5086954268 @default.
- W3092474519 hasBestOaLocation W30924745191 @default.
- W3092474519 hasConcept C126322002 @default.
- W3092474519 hasConcept C203014093 @default.
- W3092474519 hasConcept C2522874641 @default.
- W3092474519 hasConcept C2776408679 @default.
- W3092474519 hasConcept C2776455275 @default.
- W3092474519 hasConcept C2908647359 @default.
- W3092474519 hasConcept C3013748606 @default.
- W3092474519 hasConcept C529928208 @default.
- W3092474519 hasConcept C71924100 @default.
- W3092474519 hasConcept C99454951 @default.
- W3092474519 hasConceptScore W3092474519C126322002 @default.
- W3092474519 hasConceptScore W3092474519C203014093 @default.
- W3092474519 hasConceptScore W3092474519C2522874641 @default.
- W3092474519 hasConceptScore W3092474519C2776408679 @default.
- W3092474519 hasConceptScore W3092474519C2776455275 @default.
- W3092474519 hasConceptScore W3092474519C2908647359 @default.
- W3092474519 hasConceptScore W3092474519C3013748606 @default.
- W3092474519 hasConceptScore W3092474519C529928208 @default.
- W3092474519 hasConceptScore W3092474519C71924100 @default.
- W3092474519 hasConceptScore W3092474519C99454951 @default.
- W3092474519 hasIssue "Supplement_5" @default.
- W3092474519 hasLocation W30924745191 @default.
- W3092474519 hasOpenAccess W3092474519 @default.
- W3092474519 hasPrimaryLocation W30924745191 @default.
- W3092474519 hasRelatedWork W2011858350 @default.
- W3092474519 hasRelatedWork W2132259654 @default.
- W3092474519 hasRelatedWork W2167679466 @default.
- W3092474519 hasRelatedWork W2379701888 @default.
- W3092474519 hasRelatedWork W2801690772 @default.
- W3092474519 hasRelatedWork W2861307256 @default.
- W3092474519 hasRelatedWork W2994723570 @default.
- W3092474519 hasRelatedWork W3107272117 @default.
- W3092474519 hasRelatedWork W4247989843 @default.
- W3092474519 hasRelatedWork W2041911492 @default.
- W3092474519 hasVolume "30" @default.
- W3092474519 isParatext "false" @default.
- W3092474519 isRetracted "false" @default.
- W3092474519 magId "3092474519" @default.
- W3092474519 workType "article" @default.